KRAS-IN-49
KRAS-IN-49 (compound 7b) is a selective and covalent KRAS G13C inhibitor. KRAS-IN-49 covalently binds to Cys13 of KRAS G13C. KRAS-IN-49 can be used for non-small cell lung cancer (NSCLC) research.
Nos produits utilisent uniquement pour la recherche. Nous ne vendons pas aux patients.
- Formule: C28H39N9O15P2
- Masse moléculaire:803.61
-
Stockage:
Please store the product under the recommended conditions in the Certificate of Analysis.
To place orders, for customer services and technical support, please contact: MedChemExpress USA
Tel: 609-228-6898 E-mail: [email protected] [email protected]
-
Activité biologique
-
Chemical Information
- Pureté et documentation
- Références
-
Help & FAQs
Activité biologique
|
KRAS G13C |
Chemical Information
-
Masse moléculaire 803.61
-
Formule C28H39N9O15P2
-
SMILES
O=C1C(N=CN2[C@@H]3O[C@H](COP(OP(O)(O)=O)(O)=O)[C@@H](OC(N4CCC[C@@H](NC(C=C)=O)C4)=O)[C@H]3OC(N5C[C@@H](CCC5)NC(C=C)=O)=O)=C2N=C(N)N1
-
Livraison
Room temperature in continental US; may vary elsewhere.
-
Stockage
Please store the product under the recommended conditions in the Certificate of Analysis.
Pureté et documentation
Références
Calculators
Concentration (start) × Volume (start) = Concentration (final) × Volume (final)
KRAS-IN-49 Related Classifications
HY-179536 Related Classifications
Powered by Bioz